Dear Colleagues,

ECB 2023 will present the latest research related to all aspects of research on human health and diseases; the discovery and characterization of new therapeutic targets and therapeutic strategies; and research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products. Topics of interest include, but are not limited to:

• RNA Processing and Human Diseases;
• Molecular Mechanisms of Neurodegeneration;
• Extracellular Vesicles for Biomarker Discovery;
• Medicinally Active Plants and Phytochemicals;
• Wound Healing;
• Musculoskeletal Tissue Regeneration;
• Nutraceuticals as Adjuvant Therapeutics;
• Frontiers of biomedicine in SARS-CoV-2;
• Gastrointestinal Cancer;
• Immune System, Tumor Immunology, and Autoimmune Disease.

ECB 2023 is an electronic conference sponsored by Biomedicines. Participation is free of charge for authors and attendees. Accepted papers will be gathered in the proceedings of the conference. Selected extended versions of the papers will be published in a Special Issue of Biomedicines and undergo full peer review (ISSN 2227-9059; impact factor: 4.757 (2022)) with a 20% discount on the article processing charge. ECB 2023 offers you the opportunity to participate in this international, scholarly conference without the concerns or expenditure of travel—all you need is your computer and access to the internet. We would like to invite you to attend this conference and present your latest work.

Prof. Dr. Jun Lu
Dr. Allan Stensballe
Dr. Masaru Tanaka
Dr. Giuseppina Catanzaro
Dr. Zoran Minic
Dr. Stefano Bacci
Dr. Krisztina Nikovics
Dr. Sílvia A. Sousa
Prof. Dr. Ciro Isidoro
Prof. Dr. Shaker A. Mousa
Dr. Ryota Niikura
Dr. Jitka Petrlova
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.